ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 164970 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 164970; 2) Community: the network communities that were significantly associated with the response to NSC 164970; 3) Molecule: the relationships between components within communities and NSC 164970; 4) MDR: the compounds that were significantly associated with the NSC 164970.

NSC Compound Enrichment Correlation
NSC 606497 Camptothecin Derivative 0.0137891122538509 0.25724511
NSC 624657 ANTINEOPLASTIC-624657 0.0137891122538509 0.21816021
NSC 633514 Null 0.0137891122538509 0.1233773
NSC 637505 Null 0.0137891122538509 0.37329507
NSC 649904 Cyclopentanone, 5-[(4-morpholinyl)methyl]-2-pentylidene-, hydrochloride 0.0137891122538509 0.46280975
NSC 665514 Null 0.0137891122538509 0.1288461
NSC 673787 Null 0.0137891122538509 0.20309802
NSC 674182 Null 0.0137891122538509 0.094792122
NSC 679006 2-Butenedioic acid, 2,2'-(5-methyl-2,4-dioxopyrimidine- 1,3-diyl)bis-, tetraethyl ester 0.0137891122538509 0.40825354
NSC 684043 1H-Imidazole-4-carboxamide, 5-[[(2-amino-2-carboxyethyl)thio]azo]- 0.0137891122538509 0.38280793
Total:96  Current:48    [First] [Prev] [Next] [Last]